If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCorero Network Regulatory News (CNS)

Share Price Information for Corero Network (CNS)

Share Price is delayed by 15 minutes
Get Live Data
9.25    -1.25 (-12.20%)
Bid:
9.00
Ask:
9.50
Spread: 0.50 (5.556%)
Market Cap: £46.09m
CNS Live PriceLast checked at - London Stock Exchange

Intraday Corero Network Share Chart

Holding(s) in Company

2 Aug 2010 15:14

For filings with the FSA include the annex For filings with issuer exclude the annex

TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are

CORERO PLCattached:ii

2 Reason for the notification (please tick the appropriate box or boxes): An acquisition or disposal of voting rights X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments An event changing the breakdown of voting rights

Other (please specify):

3. Full name of person(s) subject to the

ROY MITCHELLnotification obligation:iii

4. Full name of shareholder(s)

(if different from 3.):iv

5. Date of the transaction and date on which the threshold is crossed or PURCHASES OF 88999 SHARES

IN JULY 2010reached: v

6. Date on which issuer notified:

29 JULY 2010

7. Threshold(s) that is/are crossed or

10%reached: vi, vii 8. Notified details:

A: Voting rights attached to shares viii, ix

Class/ Situation previous Resulting situation after the triggering transaction type of to the triggering shares transaction if Number Number Number Number of voting % of voting rights x possible of of of shares rights using Shares Voting the ISIN Rights CODE Direct Direct xi Indirect xii Direct Indirect 66833 4.4% 155832 155832 10.26%

B: Qualifying Financial Instruments Resulting situation after the triggering transaction

Type of Expiration Exercise/ Number of voting % of voting financial date xiii Conversion Period xiv rights that may be rights instrument acquired if the instrument is exercised/ converted. C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of Exercise price Expiration Exercise/ Number of voting rights % of voting rights financial date xvii Conversion period instrument refers to xix, xx instrument xviii Nominal Delta Total (A+B+C) Number of voting rights Percentage of voting rights 155832 10.26%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable: xxi

Proxy Voting: 10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease

to hold:

12. Date on which proxy holder will cease to hold

voting rights: 13. Additional information: 14. Contact name: ROY MITCHELL

15. Contact telephone number:

07777 642012

Note: Annex should only be submitted to the FSA not the issuer Annex: Notification of major interests in sharesxxii

A: Identity of the persons or legal entity subject to the notification

obligation Full name

(including legal form of legal entities)

Contact address

(registered office for legal entities)

Phone number & email Other useful information

(at least legal representative for legal persons)

B: Identity of the notifier, if applicable

Full name Contact address Phone number & email Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) C: Additional information

For notes on how to complete form TR-1 please see the FSA website.

vendor
Date   Source Headline
2nd Aug 20102:38 pmPRNHolding(s) in Company
19th Jul 20101:57 pmPRNDirector/PDMR Shareholding
14th Jul 20107:19 amPRNDisposal, fund raising and directorate change
12th Jul 20107:00 amPRNAdviser - Change of Name
19th May 20102:41 pmPRNResult of AGM
11th May 20107:00 amRNSContract Win
21st Apr 20107:00 amRNSContract Win
30th Mar 20107:00 amPRNHolding(s) in Company
26th Mar 20107:00 amPRNFinal Results
19th Mar 20107:00 amRNSContract Win
26th Jan 20107:00 amPRNTrading Statement
16th Oct 20097:00 amPRNMajor Contract Extension
15th Oct 20097:01 amPRNNOMAD Change of Name
18th Sep 20091:39 pmPRNDirector/PDMR Shareholding
17th Sep 20097:00 amPRNHalf-yearly Report
30th Jun 20094:03 pmPRNTotal Voting Rights
29th Jun 20093:27 pmPRNResult of Meeting
4th Jun 20097:00 amPRNAmendment to the CULS and Capital Reorganisation
26th Mar 20097:00 amPRNFinal Results
20th Jan 20097:00 amPRNTrading Statement
8th Aug 20087:00 amPRNHalf-yearly Report
21st May 20083:33 pmRNSResults of Meeting
19th May 20082:02 pmPRNDirectorate Change
31st Mar 200811:58 amPRNGrant of Options
25th Mar 20085:09 pmPRNDirector/PDMR Shareholding
20th Mar 20087:00 amPRNFinal Results
23rd Nov 20074:24 pmPRNDirector/PDMR Shareholding
23rd Nov 20077:00 amPRNTrading Statement and Board Changes
6th Nov 200710:52 amPRNHolding(s) in Company
6th Nov 20077:01 amRNSNew Contract for Blue Curve
27th Sep 20077:01 amRNSInterim Results
24th Sep 200710:30 amPRNChange of Registered Office
14th Aug 20077:01 amRNSContract Win
10th Aug 20073:39 pmPRNAIM Rule 26
2nd Aug 20077:02 amRNSContract Wins
27th Jul 200712:52 pmPRNDirector/PDMR Shareholding
26th Jul 20077:00 amPRNDirectorate Change and Trading Update
9th Jul 20074:35 pmPRNHolding(s) in Company
3rd Jul 20077:01 amRNSContract win
24th May 20072:50 pmPRNResult of AGM
30th Apr 20073:57 pmPRNTotal Voting Rights
25th Apr 20073:47 pmPRNHolding(s) in Company
24th Apr 200710:02 amPRNHolding(s) in Company
23rd Apr 20073:23 pmPRNHolding(s) in Company
3rd Apr 20075:25 pmPRNIssue of Equity
29th Mar 20077:01 amRNSFinal Results
27th Feb 200710:59 amPRNResult of EGM
2nd Feb 20073:34 pmRNSFurther re Change of Name
18th Jan 20077:01 amRNSChange of Name
12th Jan 20079:41 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.